BIIB

Latest SEC Filings & News for BIIB

3 most recent filings and news items mentioning BIIB. Updated every 60 seconds.

Get this data via API — free tier: 10,000 calls/day
curl "https://api.brieftape.com/v1/tickers/BIIB/news?limit=20"

Pull BIIB filings straight into your trading bot, model, or app.

Get an API key — free tier: 10,000 calls/day

Congresswoman Who Bought No Stocks In 2025 Is Back With More 2026 Trades: Here's The Shopping List

Congresswoman Who Bought No Stocks In 2025 Is Back With More 2026 Trades: Here's The Shopping List

View filing at SEC.gov →

This House of Representative Just Bought Up To $375K In Biogen Stock

This House of Representative Just Bought Up To $375K In Biogen Stock

View filing at SEC.gov →

Biogen and Denali discontinue BIIB122 development after Phase 2b failure in Parkinson's

The Phase 2b LUMA study of BIIB122 failed to meet primary and secondary endpoints in early-stage Parkinson's disease, prompting discontinuation in idiopathic PD while continuing a separate LRRK2 carrier study. The setback represents a significant clinical disappointment for both

View filing at SEC.gov →
AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.